Working... Menu

Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) (VAST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02579083
Recruitment Status : Completed
First Posted : October 19, 2015
Last Update Posted : December 19, 2018
National Institute of Allergy and Infectious Diseases (NIAID)
Boston University
The Miriam Hospital
Information provided by (Responsible Party):
LeafBio, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2018
  Actual Study Completion Date : July 2018